7 studies were found.

1.		Recruiting	Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Conditions: stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer; squamous cell carcinoma of the anus
2.		Recruiting	Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer Conditions: Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
3.		Recruiting	Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer Conditions: squamous cell carcinoma of the anus; stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer
4.		Recruiting	Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer Conditions: Anal Cancer; perioperative and postoperative complications; Rectal Cancer
5.		Recruiting	Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients with Primary Anal Cancer Conditions: Anal Cancer; basaloid carcinoma of the anus; cloacogenic carcinoma of the anus; squamous cell carcinoma of the anus
6.		Recruiting	Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus
7.		Recruiting	Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus